Highbridge Capital Management’s Mead Johnson Nutrition Company MJN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-8,631
Closed -$710K 1908
2016
Q4
$611K Sell
8,631
-23,369
-73% -$1.74M 0.01% 697
2016
Q3
$2.53M Buy
+32,000
New +$2.73M 0.04% 394
2016
Q2
Sell
-247,922
Closed -$21.1M 1994
2016
Q1
$21.1M Buy
+247,922
New +$18.4M 0.35% 75
2015
Q4
Sell
-164,651
Closed -$13M 2021
2015
Q3
$11.6M Buy
+164,651
New +$13.5M 0.18% 152
2015
Q1
Sell
-7,632
Closed -$768K 1727
2014
Q4
$768K Buy
+7,632
New +$761K 0.01% 716
2014
Q3
Sell
-2,838
Closed -$264K 1484
2014
Q2
$264K Buy
+2,838
New +$248K ﹤0.01% 911
2014
Q1
Sell
-4,447
Closed -$372K 1360
2013
Q4
$372K Buy
4,447
+1,313
+42% +$107K ﹤0.01% 767
2013
Q3
$233K Sell
3,134
-40,174
-93% -$3.01M ﹤0.01% 1130
2013
Q2
$3.43M Buy
+43,308
New +$3.47M 0.03% 385

Other funds holding MJN

Highbridge Capital Management's MJN Position: Q1 2017 in Review

Highbridge Capital Management sold out of Mead Johnson Nutrition Company (MJN) in Q1 2017, closing a stake of 8,631 shares — an estimated $710K sold.

Highbridge Capital Management first reported a position in MJN in Q2 2013 and held it in 9 quarters. The position peaked at $21.1M in Q1 2016. 533 funds tracked by Wall St. Rank hold MJN as of Q1 2017.

  • Highbridge Capital Management reported no remaining Mead Johnson Nutrition Company position as of Q1 2017 after selling out during the quarter.
  • Highbridge Capital Management sold 8,631 Mead Johnson Nutrition Company shares in Q1 2017, an estimated $710K.
  • Highbridge Capital Management first reported a position in Mead Johnson Nutrition Company in Q2 2013 and held it in 9 quarters.
  • Highbridge Capital Management's Mead Johnson Nutrition Company position peaked at $21.1M in Q1 2016.
  • 533 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q1 2017.

Based on Highbridge Capital Management's 13F filing for Q1 2017, filed 15 May 2017.